Your browser doesn't support javascript.
loading
FACTORS ASSOCIATED WITH TB/HIV CO-INFECTION AMONG DRUG SENSITIVE TUBERCULOSIS PATIENTS MANAGED IN A SECONDARY HEALTH FACILITY IN LAGOS, NIGERIA.
Adejumo, Olusola A; Daniel, Olusoji J; Otesanya, Andrew F; Adegbola, Adebukola A; Femi-Adebayo, Temitope; Bowale, Abimbola; Adesola, Sunday; Kuku, Olugbenga O; Otemuyiwa, Kehinde O; Oladega, Shafaatu N; Johnson, Eze O; Falana, Ayodeji A; Dawodu, Olusola; Owuna, Henry; Osoba, Ganiyat; Dacosta, Adetokunbo.
Afiliação
  • Adejumo OA; Department of Community Health and Primary Health Care, Lagos State University Teaching Hospital, Ikeja Lagos, Nigeria.
  • Daniel OJ; Department of Community Medicine and Primary Care, Olabisi Onabanjo University Teaching Hospital Sagamu Ogun State.
  • Otesanya AF; Medical Services Department, Central Bank of Nigeria, Lagos.
  • Adegbola AA; KNCV TB Foundation Nigeria/Challenge TB project, Abuja, Nigeria.
  • Femi-Adebayo T; Department of Community Health and Primary Health Care, Lagos State University Teaching Hospital, Ikeja Lagos, Nigeria.
  • Bowale A; Mainland Hospital, Yaba, Lagos, Nigeria.
  • Adesola S; Mainland Hospital, Yaba, Lagos, Nigeria.
  • Kuku OO; Mainland Hospital, Yaba, Lagos, Nigeria.
  • Otemuyiwa KO; Mainland Hospital, Yaba, Lagos, Nigeria.
  • Oladega SN; Mainland Hospital, Yaba, Lagos, Nigeria.
  • Johnson EO; Mainland Hospital, Yaba, Lagos, Nigeria.
  • Falana AA; Mainland Hospital, Yaba, Lagos, Nigeria.
  • Dawodu O; Mainland Hospital, Yaba, Lagos, Nigeria.
  • Owuna H; Mainland Hospital, Yaba, Lagos, Nigeria.
  • Osoba G; Mainland Hospital, Yaba, Lagos, Nigeria.
  • Dacosta A; Mainland Hospital, Yaba, Lagos, Nigeria.
Afr J Infect Dis ; 11(2): 75-82, 2017.
Article em En | MEDLINE | ID: mdl-28670643
ABSTRACT

BACKGROUND:

This study assessed factors associated with TB/HIV co-infection among TB patients managed in a secondary health facility in Lagos Nigeria. MATERIALS AND

METHODS:

A retrospective review of treatment cards of patients seen at a secondary referral hospital between January 1 2014 and December 31 2014 was conducted. Treatment outcomes and factors associated with TB/HIV co-infection were assessed.

RESULTS:

Of the 334 records of patients reviewed, the proportion of patients with TB/HIV co-infection was 21.6%. The odds of having TB/HIV co-infection was 2.7 times higher among patients above 40 years than patients less than 25 years (AOR 2.7 95% CI 1.1 - 6.5, p =0.030). In addition, the odds of having TB/HIV co-infection was 3.3 higher among extra-pulmonary TB cases (AOR 3.3; 95% CI 1.2 - 9.5; p = 0.026) and 2.1 times higher among retreated patients (AOR 2.1; 95% CI 1.1 - 3.9; p = 0.017) than pulmonary TB and new patients respectively. The chance of having TB/HIV co-infection was 2.7-fold more in patients with poor treatment outcomes than patients with treatment success (AOR 2.7; 95%CI 1.3 - 5.4; p =0.006).

CONCLUSION:

TB/HIV co-infection rate was high in the study area. There is need to put measures in place to improve treatment outcomes of TB/HIV co-infected patients.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Idioma: En Revista: Afr J Infect Dis Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Nigéria

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Idioma: En Revista: Afr J Infect Dis Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Nigéria